
Peku 40mg Tablet
Marketer
Corpus Lifesciences Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Peku 40mg Tablet
Gastric acid production is diminished by the 40mg Peku Tablet, a medication employed in treating various gastrointestinal disorders linked to excess stomach acid. These include heartburn, acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering both symptom relief and promoting healing. Peku 40mg also prevents stomach ulcers and hyperacidity often associated with prolonged nonsteroidal anti-inflammatory drug use. Classified as a proton pump inhibitor (PPI), this medication should be ingested one hour prior to meals, ideally in the morning. Dosage is adjusted based on individual needs and response, and continued use is advised even with rapid symptom resolution. Dietary modifications, such as smaller, more frequent meals and avoidance of caffeine, spicy, and fatty foods, enhance treatment efficacy. Common, generally mild, side effects may encompass nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal discomfort. Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year, might raise the risk of bone fractures, especially at higher dosages. Consult your physician regarding preventative measures against osteoporosis, such as calcium and vitamin D supplementation. Prior to commencing treatment, inform your doctor of any severe liver impairment, concurrent HIV medication use, prior allergic reactions to similar drugs, or pre-existing osteoporosis. Pregnant or lactating individuals should also seek medical counsel before initiating Peku 40mg Tablet use.
Uses of Peku 40mg Tablet
Managing heartburn, gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Peku 40mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 40mg Peku tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.
Common Side effects of Peku 40mg Tablet:
- Diarrhea
- Flatulence
- Headache
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Upper respiratory tract infection
How to use Peku 40mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 40mg Peku tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Peku 40mg Tablet works:
Acidity relief is provided by the proton pump inhibitor (PPI) Peku 40mg Tablet. This medication lessens stomach acid production, thereby alleviating heartburn and indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Peku 40mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Peku 40mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Peku 40mg tablets without significant harm to their infants. Available human data indicates minimal risk to the baby.
DrivingUNSAFE
Driving ability may be impaired by the use of Peku 40mg Tablets, which may produce adverse effects.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Peku 40mg Tablets without requiring any alteration to the prescribed dosage.
LiverCAUTION
For patients with severe hepatic impairment, the administration of 40mg Peku tablets requires careful monitoring. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Peku 40mg Tablet :
Should you forget to take your Peku 40mg Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Peku 40mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Category | PPIs |
